Abstract
Up to date, it has been reported that several bioactive natural compounds can modulate bone metabolism. It has been also disclosed that some of them simultaneously modulate the immune response. Thus, understanding the molecular mechanisms surrounding bone metabolism has moved bone research into a new era and recently the term “osteoimmunology” is coined to describe new interdisciplinary field of bone and immunology. Now, therefore bone research is one of the hot spots designing novel drugs. Notably, the role of phytoestrogens represented by isoflavones in the bone health was frequently reviewed; however only a few reviews thoroughly cover the field of bioactive natural compounds in bone metabolism. In this review, we summarize current status of representative bioactive natural compounds that modulate bone metabolism and present new therapeutic approaches in the near future by focusing on three classes of compounds phytoestrogens, polyunsaturated fatty acids and lactoferrin.
Keywords: Osteoporosis, bone, natural compounds, phytoestrogens, isoflavones, polyunsaturated fatty acids, omega-3, lactoferrin
Current Bioactive Compounds
Title: Bone Modulating Bioactive Natural Compounds: Review
Volume: 3 Issue: 3
Author(s): Kanji Mori, Dominique Heymann and Ronan Le Bot
Affiliation:
Keywords: Osteoporosis, bone, natural compounds, phytoestrogens, isoflavones, polyunsaturated fatty acids, omega-3, lactoferrin
Abstract: Up to date, it has been reported that several bioactive natural compounds can modulate bone metabolism. It has been also disclosed that some of them simultaneously modulate the immune response. Thus, understanding the molecular mechanisms surrounding bone metabolism has moved bone research into a new era and recently the term “osteoimmunology” is coined to describe new interdisciplinary field of bone and immunology. Now, therefore bone research is one of the hot spots designing novel drugs. Notably, the role of phytoestrogens represented by isoflavones in the bone health was frequently reviewed; however only a few reviews thoroughly cover the field of bioactive natural compounds in bone metabolism. In this review, we summarize current status of representative bioactive natural compounds that modulate bone metabolism and present new therapeutic approaches in the near future by focusing on three classes of compounds phytoestrogens, polyunsaturated fatty acids and lactoferrin.
Export Options
About this article
Cite this article as:
Mori Kanji, Heymann Dominique and Bot Le Ronan, Bone Modulating Bioactive Natural Compounds: Review, Current Bioactive Compounds 2007; 3 (3) . https://dx.doi.org/10.2174/157340707781695613
DOI https://dx.doi.org/10.2174/157340707781695613 |
Print ISSN 1573-4072 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6646 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
New Peptidic GnRH Antagonists Offer a Broad Range of Therapeutic Applications
Letters in Drug Design & Discovery Anticancer Properties of Flavonoids: Roles in Various Stages of Carcinogenesis
Cardiovascular & Hematological Agents in Medicinal Chemistry Construction and Comprehensive Analysis of a Special Competitive Endogenous RNAs Network to Reveal Potential Prognostic Biomarkers for Endometrial Carcinoma
Current Bioinformatics Implication of Green Tea as a Possible Therapeutic Approach for Parkinson Disease
CNS & Neurological Disorders - Drug Targets Non Steroidal Estrogen Antagonists: Current Status and Future Perspectives
Current Medicinal Chemistry - Immunology, Endocrine & Metabolic Agents Curcumin Suppresses Tumor Growth and Angiogenesis in Human Glioma Cells Through Modulation of Vascular Endothelial Growth Factor/ Angiopoietin-2/Thrombospondin-1 Signaling
CNS & Neurological Disorders - Drug Targets Ribonucleases: From Prototypes to Therapeutic Targets? (General Articles)
Current Medicinal Chemistry Potential Strategies for Minimizing Mechanism-Based Inhibition of Cytochrome P450 3A4
Current Pharmaceutical Design Identification of Novel Sesamol Dimers with Unusual Methylenedioxy Ring-Opening Skeleton and Evaluation of Their Antioxidant and Cytotoxic Activities
Current Organic Synthesis The Role of Diabetes in Molecular Pathogenesis of Cancer
Current Signal Transduction Therapy Cyclooxygenase as a Target for Colorectal Cancer Chemoprevention
Current Drug Targets Editorial A New Year of Excellence
Current Molecular Medicine Antidiabetic Drugs: Mechanisms of Action and Potential Outcomes on Cellular Metabolism
Current Pharmaceutical Design Emerging Indications for Statins: A Pluripotent Family of Agents with Several Potential Applications
Current Pharmaceutical Design Recent Developments of Steroid Sulfatase Inhibitors as Anti-Cancer Agents
Anti-Cancer Agents in Medicinal Chemistry Stem Cell Therapies
Recent Patents on Regenerative Medicine Mast Cells as Target in Cancer Therapy
Current Pharmaceutical Design Review of Estrone Sulfatase and its Inhibitors - An Important New Target Against Hormone Dependent Breast Cancer
Current Medicinal Chemistry Selective Estrogen Receptor Modulators (SERMs): Effects on Multiple Organ Systems
Current Medicinal Chemistry Isoprenylation of Intracellular Proteins as a New Target for the Therapy of Human Neoplasms: Preclinical and Clinical Implications
Current Drug Targets